Isoliquiritigenin attenuates myocardial ischemia reperfusion through autophagy activation mediated by AMPK/mTOR/ULK1 signaling
ISO treatment may induce autophagy by regulating AMPK/mTOR/ULK1 signaling, thereby improving myocardial IR injury, as a potential candidate for treatment of myocardial IR injury.
Authors
- L Zhang (ORCID: https://orcid.org/0000-0001-5486-2691)
- Zhu YingWei
- Feng Shen (ORCID: https://orcid.org/0000-0001-8119-887X)
- Liying Shen
- Zhenfeng Chen (ORCID: https://orcid.org/0000-0002-5036-5660)
- Weiwei Yu
Institutions
- Huzhou Central Hospital (CN)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1186/s12872-024-04054-z
- Citations
- 8
- Primary Topic
- Pharmacological Effects of Natural Compounds
- Type
- article
- Field-Weighted Citation Impact
- 3.73